04.21.2023 - By ReachMD
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Rajeev Raghavan, MD, M.Ed, FASN
There are several key markers of disease progression in IgA nephropathy (IgAN) that we should be aware of, and the biochemical pathways involving endothelin-1 (ET-1) and angiotensin II (Ang II) play an important role in driving that progression. Joining Dr. Charles Turck to shed light on these two pathways and how our knowledge of ET-1 and Ang II may impact the treatment landscape is Dr. Rajeev Raghavan, Program Director for HCA Kingwood Internal Medicine in Texas.